KOBO Biotech

KOBO Biotech Current Assets

The Current Assets of KOBO Biotech (531541.BO) as of Oct 27, 2026 is 378.78 M INR. In the previous year, Current Assets was 377.43 M INR — a change of 0.36% (higher).

Current Assets

378.78 MINR

YoY

0.36%

Last updated:

Current Assets of KOBO Biotech is 2024 378.78 M INR. Current Assets of KOBO Biotech was 2023 377.43 M INR. It decreases by 0.36% higher compared to the previous year.

The KOBO Biotech Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2017
1.57 B INR
Jan 1, 2018
1.57 B INR
Jan 1, 2019
1.57 B INR
Jan 1, 2020
1.59 B INR
Jan 1, 2021
1.59 B INR
Jan 1, 2022
375.20 M INR
Jan 1, 2023
377.43 M INR
Jan 1, 2024
378.78 M INR
The KOBO Biotech Current Assets history
YEARCurrent AssetsYoY
378.78 MINR+0.36%
377.43 MINR+0.59%
375.20 MINR-76.44%
1.59 BINR-0.08%
1.59 BINR+1.77%
1.57 BINR-0.22%
1.57 BINR+0.10%
1.57 BINR-0.93%
1.58 BINR+11.21%
1.42 BINR-50.90%
2.90 BINR-3.72%
3.01 BINR+29.76%
2.32 BINR+65.80%
1.40 BINR-10.93%
1.57 BINR+30.15%
1.21 BINR+68.45%
716.40 MINR-1.10%
724.40 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

KOBO Biotech Stock analysis

What does KOBO Biotech do? Kobo Biotech Ltd. focuses on manufacturing active pharmaceutical ingredients (APIs)/bulk drugs. The company operates within the pharmaceuticals sector, producing bulk drugs for the industry. Its primary market segment consists of pharmaceutical manufacturers seeking reliable API suppliers. The firm's Solapur site in India is currently inactive, with no operational activities ongoing there. The company's revenue streams derive from the sale of manufactured APIs and bulk drugs to pharmaceutical companies. These products are essential components in the production of finished pharmaceutical formulations. Kobo Biotech Ltd. serves as a key supplier within the pharmaceutical supply chain, providing critical raw materials to its clients. The business model centers on bulk drug manufacturing, with the company acting as a supplier to other pharmaceutical firms. There are no additional product lines or services mentioned beyond API and bulk drug production. The firm's focus remains strictly on the manufacturing of active pharmaceutical ingredients and bulk drugs for the pharmaceutical industry. KOBO Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about KOBO Biotech stock

Current Assets of KOBO Biotech is 378.78 M INR in 2024.

Current Assets of KOBO Biotech changed from 377.43 M INR to 378.78 M INR, representing a 0.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets KOBO Biotech since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's KOBO Biotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — KOBO Biotech

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — KOBO Biotech